Health Care
Commentary
We don’t need socialism to cut drug prices. Americans get a good deal
Nearly nine in every 10 Americans say that prescription drug prices are too high. Yet the average prescription costs less in the U.S. than in other developed countries, according to a new study from professor Tomas Phillipson, the former chairman of the White House Council of Economic Advisers. That finding ...
Health Care
New PRI Study: Reforms to Expand PACE Program Could Save Taxpayers Billions, Improve Senior Care
SACRAMENTO – A new issue brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute calls for reforms to expand the reach of the Program of All-Inclusive Care for the Elderly (PACE), a joint Medicare and Medicaid program that delivers comprehensive medical and social ...
Commentary
Medicaid At 60: A Safety Net In Need Of Serious Repair
Today, Medicaid turns 60. But this will be no diamond jubilee. What began in 1965 as a modest safety-net program has ballooned into the largest health entitlement in the country, covering nearly 80 million Americans, costing close to $900 billion a year, and delivering poor value for both patients and ...
Commentary
Doctors Deserve More Than a Token Pay ‘Raise’ from Medicare
The Trump administration is giving doctors a modest pay raise. A proposal released this month by the Centers for Medicare and Medicaid Services would, among other things, implement the 2.5% hike in Medicare physician reimbursement established by the One Big Beautiful Bill Act, which President Trump signed into law July ...
Blog
Read part 3 of a series on drug pricing
Regulations, Not Anticompetitive Actions, Are Obstructing Drug Competition
The flaws driving up costs across the broader health care landscape are also driving up the costs for innovative drugs. After all, pharmaceuticals are an integral component used in combination with the broader healthcare system. As a result, spending on medicines both influences and is influenced by the spending on ...
Commentary
America Doesn’t Have Enough Doctors. Medicare Is Making That Worse.
The United States is facing a shortage of 37,000 physicians, according to the latest research from the Association of American Medical Colleges. That deficit will more than double to 86,000 doctors by 2036. Medicare’s chronically low reimbursement rates deserve at least part of the blame. According to the American Medical ...
Commentary
How Price Controls Make a Healthy Drug Market Sick
The unspoken assumption behind the prescription drug price controls at the heart of the Democrats’ August 2022 Inflation Reduction Act (IRA) is that the pharmaceutical market is broken. According to this view, drugmakers have the power to charge whatever they want. Only a sweeping system of government price-setting can put ...
Commentary
Medicare Turns 60 This Month: It’s Time for an Intervention
On July 30, Medicare will mark its 60th birthday. Like many 60-year-olds, it’s in the throes of a midlife crisis. But unlike a harmless convertible purchase or spontaneous trip to Paris, this one midlife crisis threatens the nation’s fiscal health — and the well-being of future retirees. Read the entire ...
Commentary
Thank Obamacare for America’s insurance fraud boom
The number of Americans enrolled in marketplace plans either fraudulently or improperly reached 6.4 million in 2025 — an increase of more than one-quarter, according to an analysis published last month by the Paragon Health Institute. All of this wrongdoing will cost American taxpayers an estimated $27 billion this year. ...
Commentary
Feds right to curtail California’s Medicaid scam
On Independence Day, President Trump signed the One Big Beautiful Bill Act, which is projected to reduce enrollment in Medicaid programs throughout the country, including Medi-Cal in California. But Californians should cheer, not jeer, these coverage “losses.” The law will primarily disenroll people who should have never been covered by ...
We don’t need socialism to cut drug prices. Americans get a good deal
Nearly nine in every 10 Americans say that prescription drug prices are too high. Yet the average prescription costs less in the U.S. than in other developed countries, according to a new study from professor Tomas Phillipson, the former chairman of the White House Council of Economic Advisers. That finding ...
New PRI Study: Reforms to Expand PACE Program Could Save Taxpayers Billions, Improve Senior Care
SACRAMENTO – A new issue brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute calls for reforms to expand the reach of the Program of All-Inclusive Care for the Elderly (PACE), a joint Medicare and Medicaid program that delivers comprehensive medical and social ...
Medicaid At 60: A Safety Net In Need Of Serious Repair
Today, Medicaid turns 60. But this will be no diamond jubilee. What began in 1965 as a modest safety-net program has ballooned into the largest health entitlement in the country, covering nearly 80 million Americans, costing close to $900 billion a year, and delivering poor value for both patients and ...
Doctors Deserve More Than a Token Pay ‘Raise’ from Medicare
The Trump administration is giving doctors a modest pay raise. A proposal released this month by the Centers for Medicare and Medicaid Services would, among other things, implement the 2.5% hike in Medicare physician reimbursement established by the One Big Beautiful Bill Act, which President Trump signed into law July ...
Read part 3 of a series on drug pricing
Regulations, Not Anticompetitive Actions, Are Obstructing Drug Competition
The flaws driving up costs across the broader health care landscape are also driving up the costs for innovative drugs. After all, pharmaceuticals are an integral component used in combination with the broader healthcare system. As a result, spending on medicines both influences and is influenced by the spending on ...
America Doesn’t Have Enough Doctors. Medicare Is Making That Worse.
The United States is facing a shortage of 37,000 physicians, according to the latest research from the Association of American Medical Colleges. That deficit will more than double to 86,000 doctors by 2036. Medicare’s chronically low reimbursement rates deserve at least part of the blame. According to the American Medical ...
How Price Controls Make a Healthy Drug Market Sick
The unspoken assumption behind the prescription drug price controls at the heart of the Democrats’ August 2022 Inflation Reduction Act (IRA) is that the pharmaceutical market is broken. According to this view, drugmakers have the power to charge whatever they want. Only a sweeping system of government price-setting can put ...
Medicare Turns 60 This Month: It’s Time for an Intervention
On July 30, Medicare will mark its 60th birthday. Like many 60-year-olds, it’s in the throes of a midlife crisis. But unlike a harmless convertible purchase or spontaneous trip to Paris, this one midlife crisis threatens the nation’s fiscal health — and the well-being of future retirees. Read the entire ...
Thank Obamacare for America’s insurance fraud boom
The number of Americans enrolled in marketplace plans either fraudulently or improperly reached 6.4 million in 2025 — an increase of more than one-quarter, according to an analysis published last month by the Paragon Health Institute. All of this wrongdoing will cost American taxpayers an estimated $27 billion this year. ...
Feds right to curtail California’s Medicaid scam
On Independence Day, President Trump signed the One Big Beautiful Bill Act, which is projected to reduce enrollment in Medicaid programs throughout the country, including Medi-Cal in California. But Californians should cheer, not jeer, these coverage “losses.” The law will primarily disenroll people who should have never been covered by ...
